<DOC>
	<DOCNO>NCT02111928</DOCNO>
	<brief_summary>This observational pilot-study intend collect outcome data cohort 30 patient suffer hyper-evaporative dry eye disease treat medical device NovaTears® eye drop duration 5 7 week .</brief_summary>
	<brief_title>NovaTears® Eye Drops Observational Study</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>According NovaTears® instruction use ≥ 18 year Patients mild moderate disease hyperevaporative dry eye disease apply eye lid hygiene least 14 day Ability willingness provide write Informed Consent Ability willingness participate examination Willingness ability return follow visit Patients hypersensitivity component NovaTears® Patients contact lenses , pregnancy , breast feeding Patients non evaporate dry eye disease Patients take lipid contain eye drop require pharmacologic treatment dry eye disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>